Earnings · China A-shares
Tiansheng Pharmaceutical Group Co. Ltd. Class A (002872) earnings
Tiansheng Pharmaceutical Group Co. Ltd. Class A published its Q3 report on 2026-10-27: net profit +3.47% year on year, +6.94% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -3.96% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +3.47%
- Excl. one-offs YoY
- +6.94%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.72% | — |
| 3 days | -3.96% | — |
| 7 days | +10.25% | — |
| 14 days | +5.40% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +1.54%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥43.77M | +3.47% | +6.94% | -1.89% | -0.14 | -2.27% | -3.96% | — | — |
| 2026 interim report | 2026-08-25 | -¥24.17M | +34.16% | +33.45% | +0.35% | -0.08 | -1.25% | +9.59% | +9.59% | +15.61% |
| 2026 Q1 report | 2026-04-29 | -¥9.78M | +21.20% | +11.94% | +14.22% | -0.03 | -0.50% | +3.28% | -0.77% | -1.72% |
| 2025 annual report | 2026-04-29 | -¥55.42M | +36.59% | +41.11% | -9.76% | -0.17 | -2.80% | +3.28% | -0.77% | -1.72% |
| 2025 Q3 report | 2025-10-30 | -¥45.34M | -24.72% | +11.79% | -13.31% | -0.14 | -2.29% | +2.56% | -1.58% | +3.17% |
| 2025 interim report | 2025-08-28 | -¥36.71M | +14.84% | +13.50% | -17.49% | -0.12 | -1.85% | -3.20% | -2.00% | -7.50% |
| 2025 Q1 report | 2025-04-29 | -¥12.42M | +39.32% | +38.72% | -21.93% | -0.04 | -0.62% | +1.00% | +8.50% | +5.92% |
| 2024 annual report | 2025-04-29 | -¥87.40M | +6.09% | -6.24% | -1.66% | -0.27 | -4.27% | +1.00% | +8.50% | +5.92% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.